Efficacy of imatinib maintenance after stem cell transplantation for Ph+/ BCR :: ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease
Heike Pfeifer, Wolfgang Bethge, Stefan Schönland, Lisa Heberling et autres